Answers are grounded in this paper and cite their sources.
SUMMARY This article discusses current platelet transfusion practice and compliance with guidelines for platelet transfusions. It then focuses on the evidence for platelet transfusion practice in patients with hematological malignancies. In particular, the review addresses two main topics central to a policy of prophylactic platelet transfusion: 1 What is the evidence to indicate if platelet transfusions should be given to prevent bleeding as compared with a strategy aimed to use platelet transfusions when bleeding occurs? 2 If platelet transfusions are given to prevent bleeding, how good is the evidence to indicate what is the appropriate threshold level of platelet count?
No takes yet. Share an insight, caveat, or question.
Collins et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: